STO · SOBI.ST
Swedish Orphan Biovitrum AB
SEK 488.00+SEK 9.80 (+2.05%)
Swedish Orphan Biovitrum AB’s quoted price sits in the upper half of its reported 52-week range, 0.81% below the high.
Loading market information…
STO · AMBEA.ST · SEK
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SEK. Historical prices are not a forecast.
Ambea AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 3.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Ambea AB (publ)’s forward annual dividend is SEK 2.65 per share, paid annual. The forward yield is 1.45% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Ambea AB (publ)’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of SEK 4.38. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ambea AB (publ)’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ambea AB (publ) provides extensive health and social care provisions, encompassing accommodation, support services, educational offerings, and qualified personnel, to senior citizens and individuals with disabilities throughout Sweden, Norway, and Denmark. The company manages its operations through five primary divisions: Nytida, Vardaga, Stendi, Altiden, and Klara. The Nytida segment is dedicated to residential facilities, individual and family assistance, specialized educational institutions for children, adolescents, and adults with disabilities or psychosocial conditions, alongside various day services. Vardaga delivers care specifically for the elderly, featuring nursing homes, short-term residency options, in-home assistance, and day activity programs. Stendi addresses the needs of children, young people, and adults through personal assistance, residential living arrangements, elder care, and home-based support. The Altiden segment's portfolio includes services for the elderly, home care, general social care, and specialized disability support. Finally, Klara offers subscription-based services for mobile care teams and supplies temporary medical staff, such as physicians and nurses. Founded in 1996, Ambea AB (publ) maintains its head office in Solna, Sweden.
Latest available per-share figures in SEK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:42 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 6, 2025 | SEK 1.39-15.24% vs estimate | SEK 3.64B+0.48% vs estimate |
|---|
| Q4 2024 | Feb 12, 2025 | SEK 1.75-1.69% vs estimate | SEK 3.64B+1.84% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | SEK 3.13+13.82% vs estimate | SEK 3.56B-0.59% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 488.00+SEK 9.80 (+2.05%)
Swedish Orphan Biovitrum AB’s quoted price sits in the upper half of its reported 52-week range, 0.81% below the high.
SEK 273.40+SEK 1.50 (+0.55%)
Getinge AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 0.18% below the high.
SEK 341.60+SEK 2.80 (+0.83%)
Sectra AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 0.29% below the high.
SEK 279.50+SEK 2.00 (+0.72%)
Medicover AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 0.89% below the high.
SEK 670.00SEK 0.00 (0.0%)
Camurus AB’s quoted price sits in the upper half of its reported 52-week range, 5.63% below the high.
SEK 319.40-SEK 0.80 (-0.25%)
BioArctic AB’s quoted price sits in the upper half of its reported 52-week range, 12.35% below the high.
SEK 116.80-SEK 1.30 (-1.1%)
Attendo AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 10.29% below the high.
SEK 70.90+SEK 0.30 (+0.42%)
Humana AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 8.87% below the high.
